Phreesia, Inc.

NYSE:PHR

Medical - Healthcare Information Services

Healthcare
$12.26 +0.80%

+$0.08 today

Market cap
$760.99M
Beta
0.88
P/E (TTM)
62.6
EPS (TTM)
$0.15
52W Low $7.77High $32.76

Volume 0.86M

Average 1.97M

PHR Deferred Revenue

Payments received for goods or services the company will deliver within the next year.

Phreesia, Inc.NYSE: PHR

Deferred Revenue · Q1 FY2027 · quarter ended Apr 2026

Deferred revenue rises 27.0% from a year ago

Deferred revenue stood at $39.56M at the end of Q1 FY2027, up 27.0% from a year earlier and down 20.1% from the prior quarter. Over 3 fiscal years it compounded at +40.9% a year.

Context

  • Deferred revenue amounted to 5.9% of total assets at the end of Q1 FY2027, down 1.8 pp from a year earlier.
  • Deferred revenue increased in 3 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether deferred revenue keeps rising in the next quarterly balance sheet after a +27.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterApr 2026
$39.56M-20.1% QoQ
Last fiscal yearJan 2026
$49.52M+51.2% YoY
Year agoApr 2025
$31.15M+27.0% since
Deferred Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+27.0%——
1 year+51.2%——
3-year CAGR+40.9%——
5-year CAGR——
10-year CAGR——

Deferred Revenue history

USD · from the balance sheet

Latest · FY2026
49.52M USD
Year-over-year change
+51.2%
4-year CAGR
+31.6%

Deferred Revenue vs competitors

How PHR compares with its peers on the latest reported figures

  • PHR's Apr 2026 deferred revenue of $39.56M is the 4th highest of the 11 companies compared; the peer median is $6.11M.
  • Its year-over-year change of +27.0% is the 4th highest of 10, against a peer median of -1.7%.
  • Deferred revenue amounts to 5.9% of total assets for PHR, versus a peer median of 0.3%.
PHR Competitors Peer median
Deferred Revenue for PHR and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
OMCLOmnicell, Inc.Mar 2026$221.17M -1.7%+14.8%11.0%
SDGRSchrödinger, Inc.Sep 2026$97.67M +18.7%+24.9%16.0%
TDOCTeladoc Health, Inc.Mar 2026$65.71M -11.1%-15.1%2.3%
PHRPhreesia, Inc.Apr 2026$39.56M +27.0%+40.9%5.9%
OMDAOmada HealthMar 2026$29.35M +28.8%+23.1%9.7%
GDRXGoodRx Holdings, Inc.Mar 2026$8.63M +36.8%-5.2%0.4%
NEOGNeogen CorporationAug 2026$3.6M -38.2%-8.0%0.1%
BLFSBioLife Solutions, Inc.Mar 2026$206K +76.1%-29.1%0.1%
ESTAEstablishment Labs Holdings Inc.Sep 2026$0 -100.0%-10.6%0.0%
KMTSKestra Medical Technologies, Ltd.Jan 2026$0 -100.0%—0.0%
NVCRNovoCure LimitedMar 2026$0 —-4.0%0.0%
Peer median (excluding PHR) $6.11M-1.7%-5.2%0.3%

Competitors are the stored peer set for PHR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2022
Jan 2022
FY2023
Jan 2023
FY2024
Jan 2024
FY2025
Jan 2025
FY2026
Jan 2026
Cash & Equivalents313.81M176.68M87.52M84.22M73.83M
Short-term Investments00000
Net Receivables40.26M51.39M64.86M73.62M154.63M
Inventory1.64M1.06M768K00
Other Current Assets21.74M25.94M32.48M34.13M51.39M
Total Current Assets386.35M262.44M195.68M203.29M279.84M
Property, Plant & Equipment (Net)36.98M22.24M17.17M25.13M23.59M
Goodwill33.62M33.74M75.85M75.85M170.06M
Intangible Assets30.42M46.55M77.76M80.91M79.76M
Long-term Investments2.44M0000
Tax Assets515K81K001.59M
Other Non-current Assets4.16M5.01M3.87M3.25M108.94M
Total Non-current Assets108.13M107.62M174.64M185.13M383.95M
Total Assets494.48M370.06M370.33M388.42M663.79M
Account Payables5.12M10.84M8.48M5.62M11.48M
Short-term Debt221K246K1.1M1.22M2.66M
Tax Payables2.09M1.49M3.04M2.5M0
Deferred Revenue16.49M17.69M24.11M32.76M49.52M
Other Current Liabilities26.85M32.57M53.16M844K72.29M
Total Current Liabilities68.43M79.04M110.12M114.02M183.24M
Long-term Debt139K2.73M2.05M719K90M
Deferred Tax Liabilities2.71M1.35M270K484K4.5M
Deferred Revenue (Non-current)65K125K97K119K0
Other Non-current Liabilities(1)(2.73M)2.86M185K45.62M
Total Non-current Liabilities8.76M3.2M8.76M9.58M143.34M
Total Liabilities77.2M82.24M118.88M123.61M326.58M
Common Stock521K542K577K601K620K
Retained Earnings(429.94M)(606.08M)(742.97M)(801.5M)(799.19M)
Accumulated OCI000(51K)(382K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity417.28M287.82M251.45M264.81M337.21M
Total Debt15.8M9.18M11.98M17.8M102.45M
Net Debt(298.01M)(167.5M)(75.54M)(66.42M)28.62M

Phreesia, Inc.

NYSE:PHR

Intrinsic Alpha fair value

Locked

Current Price

$12.26

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.